Residual β-Cell Function and HLA-A24 in IDDM: Markers of Glycemic Control and Subsequent Development of Diabetic Retinopathy
The DOI matches its Crossref record.
Abstract
To identify risk factors for diabetic retinopathy in insulin-dependent diabetes mellitus (IDDM), we studied the relationships among residual β-cell function, human leukocyte antigen (HLA), long-term glycemic control, and development of diabetic retinopathy in 128 IDDM patients. Residual β-cell function was assessed by serum C-peptide immunoreactivity (CPR) response to a 100-g oral glucose load (ΔCPR). The patients were stratified into three groups: those with ΔCPR of <0.033 nmol/1 (group 1, n = 50), those with ΔCPR of 0.033–0.1 nmol/1 (group 2, n = 38), and those with ΔCPR of > 0.1 nmol/1 (group 3, n = 40). The cumulative incidence rate of background retinopathy was higher in the order of groups 1, 2, and 3 (P = 0.032). Group 1 progressed to preproliferative retinopathy at an earlier stage than did groups 2 and 3 combined (P = 0.028). Further progression to proliferative retinopathy tended to be earlier in group 1 than in groups 2 and 3 combined (P = 0.083). The mean HbA1c value rose from 9.01 ± 1.06% (mean ± SD) in group 3 to 9.75 ± 0.79% in group 2 to 10.48 ± 1.12% in group 1 (P <0.0001). In group 1, 89.6% of the patients had HLA-A24, whereas 50 and 43.6% of the patients had this antigen in groups 2 and 3 respectively (P <0.0001). In Cox's proportional hazards model, both serum CPR response and mean HbA1c value were identified as independent risk factors for development of diabetic retinopathy after adjusting for other potential risk factors. These results indicate that complete loss of β-cell function, which is associated with HLA-A24, predicts earlier occurrence of diabetic retinopathy through metabolic control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Palmer, J. P., Fleming, G. A., Greenbaum, C. J., Herold, K. C., Jansa, L. D., Kolb, H., Lachin, J. M., Polonsky, K. S., Pozzilli, P., Skyler, J. S., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.1.250 · Cited by 491
Noble, J. A., & Erlich, H. A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007732 · Cited by 335
Autoimmune Diabetes Not Requiring Insulin at Diagnosis (Latent Autoimmune Diabetes of the Adult)
Pozzilli, P., & Di Mario, U. (2001) · Diabetes Care · doi:10.2337/diacare.24.8.1460 · Cited by 284
β-cell dysfunction: Its critical role in prevention and management of type 2 diabetes
Saisho, Y. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i1.109 · Cited by 263
Murao, S., Kondo, S., Ohashi, J., Fujii, Y., Shimizu, I., Fujiyama, M., Ohno, K., Takada, Y., Nakai, K., Yamane, Y., et al. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.01.024 · Cited by 57
Metadata
- Authors
- Nakanishi, K., Kobayashi, T., Inoko, H., Tsuji, K., Murase, T., & Kosaka, K.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1995-11-01
- Volume
- 44
- Issue
- 11
- Pages
- 1334-1339
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2097837124
- Cited by
- 46
- References
- 0
- FWCI
- 1.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Residual β-Cell Function and HLA-A24 in IDDM: Markers of Glycemic Control and Subsequent Development of Diabetic Retinopathy. https://app.cochat.ai/papers/10.2337/diab.44.11.1334
- The paper
- Nakanishi, K., Kobayashi, T., Inoko, H., Tsuji, K., Murase, T., & Kosaka, K. (1995). Residual β-Cell Function and HLA-A24 in IDDM: Markers of Glycemic Control and Subsequent Development of Diabetic Retinopathy. Diabetes. https://doi.org/10.2337/diab.44.11.1334
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.